NXS 6.12% 26.0¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-6

  1. 221 Posts.
    lightbulb Created with Sketch. 121
    My hope for this quarterly was:
    1. Revenue guidance achieved.
    2. Negative Operating Cashflow trending down.

    Actual results reflect achievement of revenue guidance (on the lower end), reduction in cash burn and renewed commitment to being cashflow and EBITDA positive in H2 '24.

    I am very happy with these results. Good growth on a PCP and Q on Q basis (despite the impact of the changes made to sales mix in Q3). So to me, the growth sustainability of sales quality have both improved since the arrival of IV Hall.

    '24 Guidance of US$36 - $40m would reflect Revenue growth of between 62 and 80%. These are very good numbers and coupled with the commitment to positive cashflow & EBITDA by 2H '24 leaves me feeling very bullish.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.015(6.12%)
Mkt cap ! $75.84M
Open High Low Value Volume
25.5¢ 26.5¢ 24.5¢ $20.20K 79.07K

Buyers (Bids)

No. Vol. Price($)
1 9313 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 24500 1
View Market Depth
Last trade - 15.30pm 20/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.